Focus Area
Access & Appropriate Use
Getting the right antibiotics to the people who need them and making sure they are used properly once they arrive are two halves of one challenge. We work on both widening access where supply falls short and supporting responsible use that keeps those medicines effective.
Our Priorities
We lead industry engagement on initiatives that could pilot or scale new access models in low- and middle-income countries, and we support responsible use to guard against misuse and resistance.
Building on the commitments governments made in the 2024 UN Political Declaration on AMR, our priorities are to:
01
Put Commitments into Practice
Push for the commitments in the 2024 UN Political Declaration on AMR to be put into practice.
02
Strengthen Partnerships
Strengthen partnerships across low- and middle-income countries through targeted stakeholder mapping and engagement.
03
Keep Access on the Global Agenda
Work with governments, multilaterals, and implementers to keep access on the global agenda.
04
Build a Shared Evidence Base
Build a shared evidence base on access and appropriate use across income levels, setting out the priority challenges, policy solutions, and gaps.
The Stewardship Prize
The Stewardship Prize recognizes established, innovative approaches to antimicrobial stewardship in low- and middle-income countries and helps those programs scale. It is one of the ways the Alliance supports appropriate use: the work of keeping today’s antibiotics effective.
Each year, the Alliance awards 10,000 CHF to the winning program and features the winner across its network and events.
Resources
Explore Access & Appropriate Use Resources
Policy, research, and supporting materials on access and appropriate use of antibiotics.
AMR Industry Alliance Launches New Report on Role of Diagnostics in National Action Plans
AMR Industry Alliance Awards South Africa’s NeoAMS Program the 2023 AMR Stewardship Prize
Get in touch
Whether you’re a member, a partner, or exploring how to engage,
we’d like to hear from you.